Heuking Kühn Lüer Wojtek advised NanoRepro AG on performing a capital increase with shareholder subscription rights and in particular on drafting the required prospectus. In total, NanoRepro AG was able to place 1,142,857 new shares.
As high-speed diagnostics manufacturer, NanoRepro AG is predominantly working in health planning and prevention measures. It is betting on a fast growing market, which is shaped by the population's increasing health awareness and which will further gain in significance in the years to come. The company is among the innovation leaders in the area of self-diagnostics and currently carries 20 quick-tests in its portfolio. In addition, NanoRepro AG recently acquired recently the “alphabiol” brand and extended its product range by six complementary products in the field of food supplements.
Counsel to NanoRepro AG
Heuking Kühn Lüer Wojtek:
Boris Dürr (Lead),
Ricarda Marschall (both Capital Market Law), both Munich